Thomas Woiwode

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Edgar Cale, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Woiwode:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tempest Therapeutics, Inc. Director Common Stock 2,118,644 $5,000,000 $2.36 29 Apr 2022 Indirect
Gritstone bio, Inc. Director Common Stock 128 $244 $1.90 25 Aug 2021 Direct
Adverum Biotechnologies, Inc. Director Stock Option (Right to Buy) 40,000 12 May 2021 Direct
Passage BIO, Inc. Director, 10%+ Owner Director Stock Option (Right to Buy) 24,000 25 May 2023 Direct
Aligos Therapeutics, Inc. Director Stock Option (Right to Buy) 15,000 23 Jun 2022 Direct
Tempest Therapeutics, Inc. Director Stock Option (Right to Buy) 3,500 17 Jun 2022 Direct
Gritstone bio, Inc. Director Common Stock 0 $1.90 25 Aug 2021 Indirect

Insider Reports Filed by Thomas Woiwode

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PASG Passage BIO, Inc. 25 May 2023 1 $0 4 Director, 10%+ Owner 26 May 2023, 16:38
ALGS Aligos Therapeutics, Inc. 23 Jun 2022 1 $0 4 Director 27 Jun 2022, 16:14
TPST Tempest Therapeutics, Inc. 17 Jun 2022 1 $0 4 Director 22 Jun 2022, 16:13
PASG Passage BIO, Inc. 26 May 2022 1 $0 4 Director, 10%+ Owner 31 May 2022, 16:33
TPST Tempest Therapeutics, Inc. 29 Apr 2022 1 +$5,000,000 4 Director, 10%+ Owner 03 May 2022, 17:49
/report/000089924321034443-woiwode-thomas-2021-08-25 Gritstone bio, Inc. 25 Aug 2021 6 $0 4 Director 27 Aug 2021, 17:49
TPST Tempest Therapeutics, Inc. 01 Jul 2021 1 $0 4/A Director 20 Sep 2021, 20:13
TPST Millendo Therapeutics, Inc. 25 Jun 2021 3 $0 4 Director, 10%+ Owner 29 Jun 2021, 21:54
TPST Millendo Therapeutics, Inc. 25 Jun 2021 0 $0 3 Director 29 Jun 2021, 21:23
ALGS Aligos Therapeutics, Inc. 17 Jun 2021 1 $0 4 Director 17 Jun 2021, 17:14
ALGS Aligos Therapeutics, Inc. 11 Jun 2021 6 $0 4 Director 15 Jun 2021, 16:43
PASG Passage BIO, Inc. 27 May 2021 1 $0 4 Director, 10%+ Owner 28 May 2021, 18:06
ADVM Adverum Biotechnologies, Inc. 12 May 2021 1 $0 4 Director 14 May 2021, 20:05